{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:57:07Z","timestamp":1773129427925,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":26,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Rh\u00f4ne \u201cLigue Contre le Cancer\u201d Association"},{"name":"Association L\u00e9on B\u00e9rard Enfant Canc\u00e9reux (ALBEC)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1002\/pbc.25699","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T14:13:54Z","timestamp":1438870434000},"page":"2150-2156","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of Childhood T-Cell Lymphoblastic Lymphoma-Long-Term Results of the SFOP LMT96 Trial"],"prefix":"10.1002","volume":"62","author":[{"given":"Christophe","family":"Bergeron","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology, IHOP; Centre L\u00e9on B\u00e9rard; Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Coze","sequence":"additional","affiliation":[{"name":"Aix-Marseille University and Pediatric Department of APHM; Marseille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Segura","sequence":"additional","affiliation":[{"name":"Department of Statistics; Centre L\u00e9on B\u00e9rard; Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Pacquement","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology; Institut Curie; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[{"name":"Department of Pediatric; CHU de Rennes; Rennes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[{"name":"Department of Pediatric; Bordeaux, CHU; France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Patte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology; Gustave Roussy; Villejuif France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique (SFOP), France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"10.1002\/pbc.25699-BIB0001|pbc25699-cit-0001","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejca.2005.08.041","article-title":"Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000)","volume":"42","author":"Goubin","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1002\/pbc.25699-BIB0002|pbc25699-cit-0002","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1002\/pbc.25699-BIB0003|pbc25699-cit-0003","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mpo.2950200204","article-title":"Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma","volume":"20","author":"Patte","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"10.1002\/pbc.25699-BIB0004|pbc25699-cit-0004","first-page":"356","article-title":"Treatment of childhood lymphoblastic lymphomas-Results of the SFOP LMT 89 protocol (French Society of Pediatric Oncology)","volume":"29","author":"Bergeron","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1002\/pbc.25699-BIB0005|pbc25699-cit-0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25699-BIB0006|pbc25699-cit-0006","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.25699-BIB0007|pbc25699-cit-0007","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1002\/pbc.25699-BIB0008|pbc25699-cit-0008","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1002\/pbc.25699-BIB0009|pbc25699-cit-0009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1023\/A:1008340820288","article-title":"\u201cVANDA\u201d Protocol as treatment for lymphoblastic lymphoma (LL) relapses in children treated by SFOP LMT 89 protocol","volume":"10","author":"Bergeron","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1002\/pbc.25699-BIB0010|pbc25699-cit-0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1002\/pbc.25699-BIB0011|pbc25699-cit-0011","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","article-title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial","volume":"44","author":"Uyttebroeck","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1002\/pbc.25699-BIB0012|pbc25699-cit-0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"key":"10.1002\/pbc.25699-BIB0013|pbc25699-cit-0013","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1200\/JCO.2010.30.2877","article-title":"Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: First evidence for genetic predisposition","volume":"29","author":"Szczepanski","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25699-BIB0014|pbc25699-cit-0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjh.12460","article-title":"Disseminated lymphoblastic lymphoma in children and adolescents: Results of the COG A5971 trial: A report from the Children's Oncology Group","volume":"162","author":"Termuhlen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.25699-BIB0015|pbc25699-cit-0015","first-page":"1000","article-title":"Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease","volume":"7","author":"Goker","year":"1993","journal-title":"Leukemia"},{"key":"10.1002\/pbc.25699-BIB0016|pbc25699-cit-0016","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1172\/JCI117552","article-title":"Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia","volume":"94","author":"Synold","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1002\/pbc.25699-BIB0017|pbc25699-cit-0017","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1200\/JCO.2010.32.5340","article-title":"Shortening infusion time for high-dose methotrexate alters antileukemic effects: A randomized prospective clinical trial","volume":"29","author":"Mikkelsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25699-BIB0018|pbc25699-cit-0018","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2010-06-292615","article-title":"Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: A randomized study by the Children's Oncology Group (POG 9404)","volume":"118","author":"Asselin","year":"2011","journal-title":"Blood"},{"key":"10.1002\/pbc.25699-BIB0019|pbc25699-cit-0019","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.1993.11.3.520","article-title":"Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group report","volume":"11","author":"Tubergen","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25699-BIB0020|pbc25699-cit-0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","article-title":"Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma","volume":"24","author":"Burkhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.25699-BIB0021|pbc25699-cit-0021","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25699","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.25699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T10:43:20Z","timestamp":1625395400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25699"}},"subtitle":["T-cell Lymphoblastic Lymphoma-SFOP LMT96"],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25699","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}